Volume 30, Number 8—August 2024
Research Letter
Fecal Microbiota Transplantation for Severe Infant Botulism, China
Table
Fecal sample no. | Days after admission | Sample classification | Real-time PCR result | Isolated strain |
Mouse bioassay result |
---|---|---|---|---|---|
A1 | 3 | Before FMT | BoNTB | B | BoNTB |
A2 | 23 | Before FMT | BoNTB | B | BoNTB |
A3 | 27 | Before FMT | BoNTB | B | BoNTB |
A4 | 32 | Before FMT | BoNTB | B | BoNTB |
A5 | 33 | Before FMT | BoNTB | B | BoNTB |
A6 | 34 | FMT1 | Negative | B | Negative |
A7 | 36 | FMT3 | Negative | Negative | Negative |
A8 | 37 | FMT4 | Negative | Negative | Negative |
A9 | 38 | After FMT | Negative | Negative | Negative |
A10 | 39 | After FMT | Negative | Negative | Negative |
A11 | 182 | Follow-up | Negative | Negative | Negative |
*BoNTB, Clostridium botulinum neurotoxin B; FMT, fecal microbiota transplantation.
1These authors contributed equally to this article.
Page created: June 14, 2024
Page updated: July 22, 2024
Page reviewed: July 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.